News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


New Zealand’s wait for scarce shingles vaccine is over

New Zealand’s wait for scarce shingles vaccine is over

ZOSTAVAX™ (Zoster Vaccine Live) has arrived in NZ

Auckland. February 17, 2014 – After a prolonged wait, New Zealand has secured a continuous supply of the world’s first and only vaccine against the painful and debilitating shingles infection, which affects up to 1 in 3 people during their lives.

A new shipment of this scarce vaccine, ZOSTAVAX, has arrived and can be administered by doctors now. The vaccine has been in short supply because it is complex to manufacture and demand is high. Until recently it was primarily available only in the US but in 2013 ZOSTAVAX was added to the National Immunisation Programme in the United Kingdom, where the vaccine is funded for older adults.

“This shipment launches MSD’s long-term programme for ZOSTAVAX. We are taking orders now and anticipate being able to meet the expected demand,” comments Paul Smith, New Zealand Director, MSD.

“Anyone who has ever had chickenpox is at risk of contracting shingles, and the risk and severity of this disease increases sharply from 50 years of age. Chronic pain is the most common complication of shingles and this can last for months, even years.3 Consequently, the impact on shingles sufferers can be devastating, affecting all aspects of their home and work lives. The introduction of this vaccine will now provide a new option to help prevent this debilitating disease.”


In New Zealand, ZOSTAVAX can be administered to individuals that are 50 years or older to reduce the risk of developing shingles and its associated acute and chronic pain. ZOSTAVAX® is a non-funded prescription medicine therefore patient charges will apply for the single dose needed. More information can be found at www.shingles.co.nz

ZOSTAVAX (Zoster Vaccine Live) recently received the Prix Galien 2013 Award for Best Biotechnology Product, specifically for “excellence in scientific innovation to improve the state of human health”. The Prix Galien Award recognises outstanding achievement in the development of new medicines.
Ends

About MSD
Today's MSD is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them. MSD. Be Well. For more information, visit: www.msd.com

About the Galien Foundation

The Galien Foundation fosters, recognises and rewards excellence in scientific innovation to improve the state of human health. Its vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in 1970 in honour of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

ends

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Book Awards: Jill Trevelyan's Story Of Peter McLeavey Is Book Of The Year

The story of Wellington art dealer Peter McLeavey and his gallery has won the prestigious New Zealand Post Book of the Year 2014 in a glittering ceremony in Wellington. More>>

ALSO:

Scoop Review Of Books: King Richard

Simon Nathan reviews 'Richard Seddon, King of God’s Own': My father grew up in Wellington during Seddon’s premiership... I can recall him standing under the Seddon statue in the grounds of parliament and telling me that Seddon had more backbone than Sid Holland and all his cabinet colleagues put together.. More>>

8 October: Miley Cyrus Bangerz Tour Coming To Auckland!

Dainty Group announced today that global superstar Miley Cyrus will bring her BANGERZ TOUR to New Zealand in October this year. This will be Miley’s first ever visit to New Zealand and there will only be one Auckland show before she takes her tour to Australia. More>>

ALSO:

Music: Lorde NZ Tour Confirmed In Four Major Cities!

In what will be her first ever New Zealand headline tour, Frontier Touring and Brent Eccles Entertainment are stoked to bring you four epic shows across the country! The all ages concerts take place late October/ early November in Christchurch, Dunedin, Wellington and Auckland. More>>

ALSO:

Scoop Review Of Books: Poor Economics

A review of and excerpt from Jonathan Boston and Simon Chapple’s Child Poverty in New Zealand. More>>

Head Count: Highest Population Growth Since 2003

The country’s population grew by 67,800 people, or 1.5 percent, in the year to 30 June 2014. This came from natural increase (births minus deaths) of 29,500 and net migration (arrivals minus departures) of 38,300. New Zealand's estimated resident population was 4.51 million at 30 June 2014. More>>

Fun-Enhancement: Research To Ensure Even Game For Less Skilled Players

A University of Canterbury engineering PhD student is researching sports, such as table tennis, to ensure closer games for both better and less skilled players. More>>

Werewolf: From The Lost Continent

It’s a case of better late than never for Olivier Assayas’ marvellous After May/Apres Mai, which first screened at Venice in 2012, got a theatrical release in Australia – but not here – and only now appears on DVD, after Assayas himself has moved on. More>>

ALSO:

Werewolf: Blue Eyed & Soulful

Last year’s Muscle Shoals documentary was a reminder that on some of soul music’s most hallowed tracks, the studio band consisted of a bunch of white guys from rural Alabama... More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news